Top Markets
Coin of the day
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
Hisse Senetlerindeki Sıralama #5676
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
Hisse Fiyatı
$62.49
Son senkronizasyon: 2024-03-06
Piyasa Değeri
$2.52B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret RayzeBio, Inc. Common Stock (RYZB)

Kategori

RayzeBio, Inc. Common Stock (RYZB) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $62.49 - 2024-03-01

Gün sonu en düşük fiyat: $20.99 - 2023-09-01
RayzeBio, Inc. Common Stock için hisse fiyatı geçmişi: 2023 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2024 87.31%
2023 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.13 6.76%
CH